FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 352:1264-1265 March 24, 2005 Number 12 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Garfunkel, A. A. Related Article by Spielberger, R. PubMed Citation

To the Editor: In the editorial by Garfunkel (Dec. 16 issue),¹ which accompanies the report by Spielberger et al.² about the action of palifermin in oral mucositis, Garfunkel cites other approaches but does not mention that low-level laser therapy might be useful in decreasing the severity of chemotherapy-associated oral mucositis.³ We believe that low-level laser therapy should be included in a randomized trial of palifermin in patients with oral mucositis.

Ahmad Awada, M.D., Ph.D.
Marie-Thérèse Genot, M.D.
Jean Klastersky, M.D., Ph.D.
Jules Bordet Institute
B-1000 Brussels, Belgium
ahmad.awada@bordet.be

1. Garfunkel AA. Oral mucositis -- the search for a solution. N Engl J Med 2004;351:2649-2651. [Free Full Text]
2. Spielberger R, Stiff P, Bensinger W, et al. Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med 2004;351:2590-2598. [Free Full Text]
3. Genot M-T, Klastersky J. Low level laser for prevention and therapy of oral mucositis induced by chemotherapy and/or radiotherapy. Curr Opin Oncol (in press).

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.